Table 1.
0–24 mo |
>24 mo |
||||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
OS | RPA class | ||||
III | – | – | – | – | |
IV | 1.64 (1.30, 2.08) | <.0001 | 1.27 (0.79, 2.05) | .33 | |
V | 2.91 (2.21, 3.82) | <.0001 | 1.69 (0.79, 3.65) | .18 | |
Radiation type | |||||
USA | – | – | – | – | |
European | 0.98 (0.80, 1.22) | .88 | 0.88 (0.44, 1.76) | .71 | |
MGMT status | |||||
Methylated | – | – | – | – | |
Unmethylated | 1.78 (1.46, 2.17) | <.0001 | 1.52 (0.94, 2.45) | .09 | |
Treatment | |||||
Standard dose | – | – | – | – | |
Dose dense | 1.03 (0.88, 1.22) | .70 | 0.99 (0.65, 1.50) | .97 | |
0–6 mo |
>6 mo |
||||
HR (95% CI) | P | HR (95% CI) | P | ||
PFS | RPA class | ||||
III | – | – | – | – | |
IV | 1.31 (1.00, 1.71) | .05 | 1.68 (1.28, 2.21) | .0002 | |
V | 1.89 (1.38, 2.59) | <.0001 | 2.35 (1.65, 3.36) | <.0001 | |
Radiation type | |||||
USA | – | – | – | – | |
European | 0.82 (0.63, 1.07) | .14 | 0.98 (0.75, 1.29) | .90 | |
MGMT status | |||||
Methylated | – | – | – | – | |
Unmethylated | 1.47 (1.17, 1.86) | .001 | 1.80 (1.42, 2.27) | <.0001 | |
Treatment | |||||
Standard dose | – | – | – | – | |
Dose dense | 0.70 (0.58, 0.86) | .0005 | 1.12 (0.90, 1.38) | .32 |